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SUMMARY
Challenges in the production of integral membrane proteins for structural studies include low
expression levels, incorrect membrane insertion, aggregation and instability. In this report, we
describe a “funnel approach” to overcome these difficulties, and demonstrate its efficacy in a case
study of 36 prokaryotic P-type transporters. A diverse ensemble of modified constructs are generated
and tested for expression in E. coli, membrane localization, detergent extraction, and homogeneity.
High throughput methodologies are implemented throughout the process to facilitate identification
of promising targets. We find that the choice of promoter, the choice of source organism providing
the cloned gene, and most importantly the position of the affinity tag have a great effect on successful
production. The latter had pronounced effects at all tested levels, from expression levels observed in
whole cells, to extent of membrane insertion, and even on protein function. Following the initial
stream lined screening, we were able to fine tune and produce 9 of the 36 targets as material suitable
for crystallization or other structural studies.
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INTRODUCTION
The passage of most biologically relevant molecules across the permeability barrier created by
the cell membrane is mediated by specialized membrane proteins known as transporters. The
significance of transport processes to cellular metabolism is emphasized by the observation
that over 550 families of transporters have been identified through biochemical and genomic
analyses1 (http://www.tcdb.org) Despite recent successes and advances2, structural studies of
transporters remain a formidable challenge. The relative paucity of structural information
stands in clear contrast to the interest and importance of these proteins as pivotal participants
in all physiological processes. Moreover, their membrane localization makes them attractive
pharmaceutical targets, and an increasing number of transporters have been directly implicated
in human diseases3–8. An example of the physiological significance of membrane proteins
may be provided by the P-type ATPases, a family of transporters characterized by unique
signature motifs, functional, and structural features9. Members of this family include the
Na+/K+-ATPase, the gastric H+-ATPase, and the sarcoplasmic reticulum (SR) Ca+2-ATPase.
Corresponding author: Douglas C. Rees. e-mail: dcrees@caltech.edu; telephone: 626-395-8393; fax: 626-744-9524.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers
we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting
proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could
affect the content, and all legal disclaimers that apply to the journal pertain.
Published as: J Mol Biol. 2008 March 14; 377(1): 62–73.
H
H
M
I Author M
anuscript
H
H
M
I Author M
anuscript
H
H
M
I Author M
anuscript
The hallmark of this family of pumps is the formation of a phospho-enzyme intermediate (hence
the name P-type ATPase), by the transfer of the γ-phosphate from ATP to a conserved aspartic
residue. To date, only the structure of the SR Ca+2-ATPase has been solved due to pioneering
work by Toyoshima and colleagues10. Structures of this pump in multiple conformations,
representing various intermediates in the catalytic cycle of the enzyme, have provided an
explicit transport mechanism for the SR Ca+2-ATPase and other P-type ATPases11–13.
Transition metal transporters that catalyze the extrusion of metals such as copper, zinc, lead,
mercury, cadmium, manganese and magnesium, constitute a sub-class of P-type ATPases
loosely referred to as “heavy-metal” or type P1B 14. While transition metals are crucial
participants in many enzymatic reactions, intra-cellular concentrations of these metals are
carefully controlled since elevated levels are toxic. Transition metal P-type ATPases participate
in this process by pumping the cognate metals across the membrane; malfunctions of these
proteins can lead to pathologies as manifested in the Wilson and Menkes diseases15. In view
of their physiological functions, we have focused on this sub-group of transporters for structural
analysis.
A variety of obstacles litter the path towards successful crystallization of a transporter or any
other membrane protein. Not only do these proteins need to be over-expressed, correctly folded
and inserted into the plasma membrane in vivo, they need to be subsequently extracted from it
in vitro. Following extraction, the detergent solubilized protein must be purified while retaining
stability. To overcome these obstacles, we have developed a “funnel approach” based on the
screening of multiple constructs to identify those suitable for structural studies16. This is the
same strategy utilized by Kendrew in the original structure determination of myoglobin17,
except that rather than obtaining homologous proteins from different natural sources, one can
now amplify the desired targets from genomic DNA. The basic idea is that if there is a 90%
chance that a given protein will fail to crystallize, the probability that two different proteins
will both fail is reduced to 0.92 = 81%; i.e., success is more likely the more proteins that are
tried. As practically implemented for prokaryotic transporters18, ~30 homologous genes of
interest are chosen from a variety of host genomes. A diverse pool of constructs is generated
from these genes, where each gene is represented by several slightly modified constructs. This
pool of constructs is then subjected to a series of sequential tests aimed at judging their
suitability for structural studies. Promising candidates proceed to the next stage, while the rest
of the ensemble is discarded. The number of potential targets dwindle as more tests are applied,
therefore the funnel effect. The goal is to start with enough proteins so that one or more will
survive to the end.
In the present work, we have amplified genes of 36 P-type ATPases from 11 different genomes
and sub-cloned each gene into four different expression vectors (Table 1). The expression
vectors harbor a poly-histidine affinity tag at either the N-terminus or C-terminus position, and
several constructs were also fused to an additional affinity tag. Further diversity is achieved
by utilizing either the T7 or arabinose promoters. An initial collection of 144 constructs was
introduced into five different E. coli strains, and expression in whole cells lysates was evaluated
using high throughput techniques. Highly expressed proteins were then tested for membrane
localization followed by detergent extraction screens. We find that the identity and location of
the fused affinity tag has a significant effect at all stages, from expression levels observed in
whole cells, through membrane localization of the expressed proteins, detergent extraction,
protein aggregation and stability, and even on protein function in-vivo. N-terminal tagging is
generally preferable to C-terminal tagging, and transcriptional control by the T7 promoter often
results in higher expression than by the arabinose promoter. By using a combinatorial approach
of multiple genes, constructs, and host strains, we were able to over-produce 24 out of 36
chosen targets. 20 of these proteins were amenable to detergent extraction, and were purified
using single step metal-affinity chromatography. Following purifications, candidate proteins
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were assayed for mono-dispersity and stability. By combining high throughput methodology
with standard biochemical methods, 25% (9/36) of the target proteins could be prepared in
purified, mono-disperse and stable form suitable for crystallographic trials.
RESULTS
Amplification and molecular cloning of target genes
It has been our experience and those of others19–21 that the expression level and properties
of a given gene product are often affected by the type and position of the fused affinity tag.
Accordingly, as detailed in the Materials and Methods section, we created a collection of
constructs where each target gene is represented by several slightly modified clones. A custom
multiple cloning site was engineered and inserted in place of the original multiple cloning sites
of pET19b, pET21d+ (Novagen, CA), pBAD/HisA and pBAD Myc-his-C (Invitrogen, CA).
The modified vectors contained only the His-tag at either the N-terminal or C–terminal
positions. All other fusions/additions originally present in these vectors were removed. Due to
the identity of the multiple cloning sites in all vectors, each target gene was amplified using
only one set of oligonucleotides. Our final collection of clones consisted of 144 constructs
representing different versions of 36 genes. In general (with a few exceptions), the following
variants were constructed for each of the target genes: N-terminal His tag, C-terminal His tag,
transcriptional control via the T7 promoter, and transcriptional control via the arabinose
promoter. In several cases, a second affinity tag was also introduced.
Testing expression in whole cells
To simplify expression testing, plasmid DNA for the 144 clones was stored in 96 well plates.
Similarly, chemically competent cells of the host strains were prepared in 96 well plate format.
Standard transformation protocols were used, and transformed cells were plated onto an LB
agar tray divided to a grid of 48 squares (Q-trays, Genetix USA). The optical densities of
150μl cultures were continuously monitored in an automated plate reader (Saffire II, Tecan
Austria), which facilitated mid log-phase induction (figure 1A). The growth curves of the
cultures harboring the different pBAD (arabinose promoter) constructs were more uniform
relative to those harboring the pET (T7 promoter) constructs (compare figure 1A left and right
panels, respectively). Post induction, the pBAD constructs generally continued to grow
normally, while the growth of many of the pET constructs stopped, with some cultures lysing.
The initial expression studies for all clones utilized E. coli strain BL21 (DE3) GOLD™
(Stratagene). Expression was tested at three different temperatures (37°, 28°, 23°), along with
variations in duration of induction times and inducer concentrations (see Materials and
Methods for details). To semi-quantitatively assess the results, expression levels were
categorized relative to the expression level of the vitamin B12 transporter BtuCD that was
previously found to express and purify well18. The His-tagged protein content of each culture
well was analyzed using dot-blot techniques (Figure 1B). 62 of the 144 clones showed
expression levels equal to or higher than BtuCD and were defined as High level expressors;
29 clones showed expression levels 2–3 fold lower than BtuCD (i.e. Medium level), and 52
clones had very low expression levels (i.e. Low level).
The most evident observation that emerges from this set of experiments is the significant
influence of the affinity tag location. In many instances, an N-terminal His-tagged protein
expresses well, while the same protein tagged at its C-terminal did not (figure 1B, compare
well C6 to well C7). The opposite situation was also observed, although at lower frequency
(figure 1C). More striking are incidents where the presence of a second tag, adjacent to the
His-tag, changes the expression level of a given protein (figure 1B, compare well F6 to well
F7). The choice of promoter is also important, as the T7 promoter typically resulted in higher
expression than the arabinose promoter, although again there are exceptions (figure 1C).
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Another factor that influences expression levels is the temperature of induction. In 138 clones
out of the tested 144 (~96%), the best results were obtained when inducing for two to three
hours at 28°.
We next explored whether we could improve expression by using different E. coli strains. All
constructs that expressed poorly in the BL21 (DE3) GOLD strain were introduced into four
additional strains: BL21(DE3)RIPL™, BL21(DE3)Star™, BL21(DE3)C41/pLysS and BL21
(DE3) C43/pLysS. The BL21(DE3)RIPL™ strain carries a plasmid encoding t-RNAs for
codons rarely used in E. coli; however, none of the constructs tested in this strain showed
elevated expression. 16% of tested clones showed somewhat elevated expression with the
BL21(DE3)C41 pLysS and BL21(DE3)C43 pLysS strains that were selected for enhanced
membrane protein expression22. The biggest improvement was observed with the BL21(DE3)
Star™ strain containing a mutation in the rne131 gene. This strain is characterized by greater
mRNA stability and indeed, 60% of the tested clones showed increased levels of expression.
Overall, by using this combination of constructs and host strains, we were able to overexpress
82 constructs, representing 35 of the 36 target genes.
Membrane localization of the expressed proteins
While overexpressed membrane proteins can successfully integrate into the plasma
membrane23–25, in other cases, they may not correctly incorporate into the plasma membrane
and instead form insoluble aggregates or inclusion bodies26; 27. Despite the time consuming
nature of membrane fraction preparations, we wished to examine the correlation between
expression levels observed in the whole cells lysates and expression levels in the membrane.
We thus prepared membrane vesicles from 63 of our highest expressing clones, representing
35 different genes. Surprisingly, only 29 of the 63 (46%) constructs found to express at high
levels in whole cell lysates also highly expressed in the membrane fraction (again, relative to
the corresponding levels of BtuCD). 8 of these 63 (13%) were present at low levels, despite
their high presence in the whole cell lysates. 26 of the 63 (41%) were completely absent from
the membrane fraction and were only found in the pellet of the low-speed centrifugation
following cell disruption, suggesting that they were present as inclusion bodies or aggregates.
7 of the 34 clones (20%) that localized poorly to the membrane of the BL21(DE3) GOLD strain
could be expressed at higher levels in the BL21(DE3)Star™ strain. Overall, 36 constructs
representing 24 different genes were found to express in the membrane at levels higher than
or equal to the expression level of BtuCD (Table 1).
As observed in lysates of whole cells, the type and position of the affinity tag can also influence
the extent of membrane incorporation. When examining pairs of constructs of the same gene
that showed similar expression levels in the whole cell lysates, several cases were observed
with pronounced differences in membrane fraction content (figure 2A). Differences were not
only manifested in expression levels, but also by the presence of additional bands in SDS-
PAGE analysis. These bands, often of smaller size, presumably represent degradation products
or products of incomplete translation. We also noted that in several of the examined pairs, a
second affinity-tag (adjacent to the His-tag) resulted in alteration of the extent of membrane
incorporation and in the appearance of additional bands (figure 2A). As with whole cell
expression, N-terminal tagging also proved advantageous with respect to levels of membrane
expression, since 64% of the clones that were highly expressed in the membrane were tagged
at their N-terminus (figure 2B).
At the whole cell level, transcription regulation by the T7 promoter resulted in higher
expression levels than those achieved by the arabinose promoter (figure 1C). This difference
was less pronounced in membranes, however, as 40% of the highly expressing proteins in this
case were expressed as pBAD constructs, relative to only 13% at the whole cell level (compare
figure 1C to figure 2B). In general, the correlation between expression levels in whole cells
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and in the membrane was better for the pBAD constructs than that of the pET constructs. Figure
2C shows a semi-quantitative analysis (see Material and Methods for details) of this effect for
a subset of 24 pBAD constructs and 24 pET constructs representing a wide range of expression
levels (0.75 to 6.8 μg/ml for the pBADs, 2.6 to 17.2 μg/ml for the pETs). The correlation
between whole cell and membrane expression for the pBAD constructs is essentially linear
over the whole expression range. In contrast, the correlation between whole cell and membrane
expression is much less evident for the pET constructs (figure 2C right panel, solid line).
Interestingly, for the subset of pET constructs expressing at lower levels (in the range of 2.6
to 8 μg/ml), a linear fit is clearly evident (figure 2C right panel, dashed line) and similar to the
fit of the complete set of pBAD constructs.
Detergent extraction of membrane proteins
An essential step in crystallographic studies of membrane proteins is their detergent-mediated
extraction from the membrane. The choice of detergent is crucial, since it has significant
implications for protein oligomeric state, integrity and function. Changes in head group size,
chemical nature, and chain length can result in inactivation of the target protein, a highly
undesirable consequence28–30. Moreover, detergent molecules may also effect crystal
formation, and often a membrane protein that will crystallize in one detergent will not
crystallize in another. Of the plethora of commercially available detergents, we opted to test
only the following four: N,N-dimethyldodecylamine-N-oxide (LDAO), octyl-β-D-
glucopyranoside (OG), dodecyl-β-D-maltoside (DDM), and dodecyloctaoxyethylene
(C12E8). These detergents have been successfully used in the past in functional and
crystallographic studies of numerous membrane proteins (for a comprehensive list see
http://blanco.biomol.uci.edu/Membrane_Proteins_xtal.html, http://www.mpdb.ul.ie, and
http://www.mpibp-frankfurt.mpg.de/michel/public/memprotstruct.html); furthermore C12E8
was used in the crystallization of rabbit SR Ca+2-ATPase10. Membrane preparations of each
protein were placed in a 96-well plate and the test detergent was added directly to the wells.
Following agitation, soluble and insoluble fractions were separated by brief ultracentrifugation.
Figure 3A shows the results of such an extraction assay. 29 of the 36 constructs (representing
20 genes) could be extracted in soluble form with at least one of the test detergents, and often
with more than one. The most efficient detergent was DDM, closely followed by LDAO.
Overall, OG resulted in lower extraction levels than with either DDM or LDAO, while the least
efficient detergent for extraction was C12E8. When the membranes were treated with the more
aggressive detergent Fos-choline 14 (FC-14), much higher extraction levels were observed. In
some instances, proteins that could not be extracted at all with the four “mild” detergents were
efficiently extracted by FC-14 (Figure 3B).
Purification and stability of the chosen targets
We next proceeded to purify twenty proteins that showed adequate levels of membrane-
associated expression and could be extracted with at least one of the mild detergents. Most of
these proteins (17/20) could be purified to 80–90% homogeneity using single step metal affinity
chromatography. Figure 4 shows an ensemble of such purifications, representing different
levels of purity and yields. In general, yields varied between 0.5 and 2 mg of pure protein per
liter of culture. Since our goal at this stage of the process is the initial identification of promising
targets, we did not attempt to further refine these crude purifications. Rather, we proceeded to
examine the mono-dispersity and stability of the selected targets. For this purpose, each of the
purified proteins was concentrated to 10–20 mg/ml and injected onto a gel-filtration column
(Superdex 200, GE Healthcare). These concentrated protein preparations were stored either at
4°C or room temperature, or snap-frozen in liquid nitrogen and stored at −80 °C. Following
7–10 days of storage at the different temperatures, the protein samples were re-analyzed by
gel filtration chromatography. Figure 5 shows the elution profiles of several proteins, both at
the time of preparation and following storage. While certain proteins displayed an elution
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profile that was independent of storage length or temperatures, others that initially exhibited a
high level of mono-dispersity developed additional peaks corresponding to higher molecular
weight species upon storage. In some of the latter cases, a high molecular-weight peak eluting
in the void volume of the column (representing protein aggregation) could be removed by
ultracentrifugation (Figure 5B). Mono-dispersity is often affected by the type of detergent used
for extraction, and this choice may need to be re-evaluated at this stage (Figure 5C). Of the 17
proteins subjected to this analysis, 9 were found to retain mono-dispersity under all tested
conditions and were consequently categorized as suitable targets for crystallization trials.
DISCUSSION
In recent years, two general approaches for the structural analysis of membrane proteins have
emerged of. The first approach capitalizes on intimate knowledge of a specific protein of
interest that often derives from years of comprehensive research. Functional, structural and
genetic data are combined to find conditions that will allow crystallization of a single, specific
membrane protein. Notable examples of membrane embedded transporters whose structures
have been so determined are the lactose permease31 and the sodium/proton transporter
NhaA32 from E. coli. In contrast, the second approach targets a related family of proteins,
rather than a specific protein, taking advantage of the large number of homologues that have
been identified through genomic sequencing studies to identify particular proteins amenable
to structural study. This funnel approach to membrane protein structure was employed, for
example, in our structural analysis of the mechanosensitive channel of large conductance16.
The fundamental basis to the funnel approach is diversity and selection. For prokaryotic targets,
30 to 40 homologues are typically cloned and inserted into multiple expression vectors. This
pool of constructs is then tested for expression in several E. coli strains. As expression levels
observed in whole cells do not necessarily correspond to expression in the membrane fraction,
the second stage of our screen is to test the highly expressing clones for membrane localization
of the protein targets. Once membrane-fraction localization is confirmed, several mild
detergents are assayed for their extraction ability. Metal-affinity chromatography is then used
for initial purification, and the mono-dispersity of the purified proteins is evaluated using gel-
filtration chromatography. Proteins exhibiting a high level of mono-dispersity are then re-
examined following storage at different temperatures. Only those proteins that express at
adequate levels in the membrane fraction, can be extracted using a mild detergent, purified to
near homogeneity, and display mono-dispersity over time are considered promising targets for
crystallization trials.
In the present report, we describe the feasibility and analyze the various stages of the funnel
approach as exemplified in a study of 36 metal P-type transporters.
Target selection
Our initial selection of targets was based primarily on the availability of genetic material.
Nevertheless, a closer look at the results suggests that a more rational choice at the initial stage
of such a project may lead to higher success rates. In the study described here, proteins found
to express well in the membrane fraction were clustered according to their taxonomy.
Membrane-associated expression was highest (see Table 1) for proteins from organisms
belonging to the same phylum as E. coli, the proteobacteria. Even within this phylum, notable
differences between classes were apparent. In addition to the three E. coli proteins, almost all
of α, β, or γ subdivisions proteins expressed at high levels (13 out of 14 tested). In contrast,
only 1 of the 6 tested ε-subdivision proteins expressed well. Success rates were also low (1 out
of 4) for the Streptococcus pneumoniae proteins, a bacterium that belongs to a different phylum
(Firmicutes) and thus further removed from E. coli. Due to the relative low number of subjects,
the statistical significance of these observations is questionable. (This is also true for the
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archaeal genes where only 1–2 genes from a given organism were tested.) However, it seems
that successful expression may be influenced by the taxonomic proximity between the host
organism and the source organism. This proposal may be supported in part by the observation
that a substantial majority of polytopic α-helical membrane proteins whose structures of have
been solved to date have been produced from their native tissues. No structure of an ε-
subdivision membrane protein has been solved, despite the considerable attention that
Helicobacter pylori has received in recent years. In comparison, several structures of
membrane proteins derived from γ-proteobacteria have been reported, including those of
transporters. In all these cases, the proteins have been produced in E. coli33. In this regard, it
is interesting to note that the membrane composition of E. coli and other γ-proteobacteria is
quite similar, yet very different from that of ε-subdivision bacteria (Campylobacter jejuni,
Helicobacter pylori)34–37. Clearly, more detailed studies are necessary in order to establish
such a connection, but the hypothesis that genetic proximity and/or compatible membrane
compositions may effect successful heterologous expression is appealing.
Choice of promoter
Each of the tested proteins was expressed under control of the T7 or arabinose promoters. When
expression level was estimated by analyzing protein content of whole cell lysates, the T7
promoter appeared to be greatly advantageous (Figure 1C). However, when expression level
was estimated by analyzing protein content in the membrane fraction, this apparent advantage
was greatly diminished (Figure 2B). The correlation between expression level observed in
whole cell lysates and that observed in the membrane fraction was better for proteins expressed
under the control of the arabinose promoter (Figure 2C). The observation that proteins
expressed under control of the T7 promoter more often resulted in insoluble aggregates may
be due in part to very high levels of expression that exceed the capacity of the membrane. It
may also be that the rate of translation exceeds the maximal rate of insertion. To partially solve
the problem of membrane incorporation, one may try to slow down the rate of translation. This
can be achieved by either lowering the temperature (post induction) and by varying the
concentration of the inducer. In our hands, almost without exception, improved membrane
integration was achieved this way without compromising total yields.
Effects of the affinity tag position
The location and identity of the affinity tag had a dramatic effect on expression levels (Figure
1) and on the extent of membrane insertion (Figure 2). Generally, N-terminal tagging resulted
in higher levels of membrane-inserted protein. Nevertheless, for about 1/3 of the proteins C-
terminal tagging was preferable. The magnitude of the “tag effect” was quite surprising,
sometimes altering expression by 100 fold (Figures 1&2). Due to the extent of these effects,
and since the goal of X-ray crystallography is to provide information on correctly folded and
functionally relevant proteins, we extended our investigation of the “tag effect” to functional
studies. Activity as a function of tag position was determined for 4 proteins using in-vivo metal
resistance assays38. Essentially, the proteins were tested for their ability to rescue the growth
of E. coli GG48, a Zn+2/Cd+2 sensitive strain39. In 3 out of the 4 test cases, significant
differences between activities of the N-terminus and C-terminus versions were observed
(Figure 6A–C). For example, at 60μM ZnCl2 the C-terminus version of Ralstonia
metallidurans ZntA did not support growth any better than the empty vector, while the growth
of cells expressing the N-terminus version was inhibited only by 40% (Figure 6A). The opposite
was true for Ralstonia metallidurans CadA (Figure 6B), where the C-terminus version
performed better. The most obvious differences were observed in the case of Cu(6)–ZntA, the
human-E. coli chimera (Table 1). Regardless of metal concentration, the C-terminus version
conferred no growth advantage relative to the empty vector, whereas cells expressing the N-
terminus version grew substantially better (Figure 6C). Only in the case of Eschericia coli
ZntA, the growth phenotypes seemed independent of the position of the tag (Figure 6D). The
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observed differences could not be attributed to differences in expression levels, since with both
Ralstonia metallidurans CadA and Cu(6)–ZntA, the more active form was the one that
expressed to a lesser extent. For many transport proteins, simple growth rescue experiments
can be performed at the early stages of the screening process. For importers, that assay may
be based on growth rescue under conditions of a limiting concentration of a relevant metabolite.
For exporters, increasing concentrations of a toxic compound can be used, as was shown here
and extensively performed with multidrug transporters. The simplicity of these assays,
combined with the abundance of E. coli deletion strains that can be used as hosts, make these
approaches readily accessible. Early identification of the active/inactive form of the target
protein may save much labor and time. In retrospect, our efforts aimed at the large-scale
production, purification and stabilization of the C-terminus version of Ralstonia
metallidurans ZntA (Figure 4) probably would have been better directed towards the N-
terminus tagged version of the same protein.
A recent study by von Heijne and colleagues 40 demonstrated the effect of point mutations of
charged residues on membrane protein topology and membrane insertion. In light of these
findings, it is not surprising that addition of multiple positively charged imidazoles at either
the N- or C-termini could have profound effects on overall expression, membrane
incorporation, and even function.
Choice of detergent
Once membrane integration of the target proteins is established, a suitable detergent must be
identified for membrane extraction. In the absence of prior functional or structural knowledge
of the protein, a good starting point is to employ detergents used previously in structural studies.
Three detergents stand out with respect to successful crystallization of polytopic inner
membrane proteins: N,N-dimethyldodecylamine-N-oxide (LDAO), octyl-β-D-
glucopyranoside (OG) and dodecyl-β-D-maltoside (DDM); dodecyloctaoxyethylene (C12E8)
was also tested since it was used in the crystallization of the Ca+-ATPase. With these four
detergents, 20 of the 24 membrane proteins (29 of 36 constructs) could be extracted from the
membrane, with DDM displaying the highest efficiency (Table 1). When mild detergents fail,
more aggressive ones may be more effective. Treatment with Fos-14 resulted in much higher
levels of extracted protein, and almost all of the tested proteins could be extracted using this
detergent (figure 3). For reasons mentioned above, however, caution should be exercised when
using harsh detergents. Fos-14 for example, has been reported to be used in the structural
analysis of only one protein, MscS41, and it is likely that the structure may not correspond to
the closed, resting state present in the membrane42.
A summary of the various stages of the funnel approach presented in this work is depicted in
Figure 7. Starting with 144 constructs (representing 36 genes), expression is first tested in
whole cells. Each of the constructs was introduced into five different E. coli strains and tested
for expression at different temperatures. Despite the large number of combinations (~2000)
this step is quite brief, as high throughput methodology allows for rapid identification of
promising candidates43. This relatively rapid stage allowed us to identify favorable conditions
for expression of 82 constructs, and to eliminate poorly expressing constructs from further
consideration. As a next step, membrane fractions were prepared, and membrane-associated
expression was evaluated. 36 constructs (representing 24 genes) proved to be adequately
incorporated in the plasma membrane, and were tested in detergent-extraction assays. 29 of
these constructs (representing 20 genes) were sufficiently extracted using mild detergents,
while the complete set could be extracted using harsher ones. A subset of 20 constructs,
representing 20 genes, was subsequently purified using single step metal chromatography. 17
of these were purified to 80–90% with yields of 0.5–2 mg of pure protein per liter of culture.
Of these 17 proteins, 9 displayed the desirable single-peak appearance when analyzed by gel
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filtration chromatography, and maintained the same appearance over time (Table 1). The
overall yield reported here (9/36; 25%), combined with the increasing number of potential
targets identified through genomic sequencing, provides a basis for some optimism that the
structural characterization of prokaryotic membrane proteins is a tractable objective.
MATERIALS AND METHODS
Unless otherwise stated, all chemicals were purchased from Sigma, and detergents from
Anatrace.
Bacterial strains and molecular cloning techniques
E. coli strains BL21 (DE3) GOLD and BL21(DE3)RIPL were from Stratagene. Strain BL21
(DE3)Star was from Invitrogen and strains BL21(DE3)C41/pLysS and BL21(DE3) C43/pLysS
were purchased from Lucigen Corporation. Restriction enzymes were from Roche diagnostics,
and DNA polymerase was purchased from Finnzymes. Sequences of oligonucleotides used for
amplification of target genes are available upon request. The original multiple cloning sites
(MCS) of pET19b, pET21d+ (Novagen, CA), pBAD/HisA, and pBAD Myc-his-C (Invitrogen,
CA) were replaced with the following MCS:
GAATTCGGTACCGTACGCTCGAGCTCTTCGAA.
Plasmid DNA was stored in 96-well format as were chemically competent cells of the host
strains. Standard protocols were used to perform transformations in 96-well format.
Expression testing in whole cells
Single colonies were used to inoculate 150 μl of Luria Bertani medium in 96-well plates. To
avoid precipitation, overnight cultures were grown at 30° under vigorous agitation (300 rpm).
Cultures were then diluted 50 fold into 150 μl of Terrific Broth media and grown in an
automated plate reader (Saffire II, Tecan Austria). Cell growth was conducted at temperatures
of 23°, 28°, or 37°. Depending on the growth temperature, expression was induced as follows:
23°: 0.1 mM IPTG or 0.02% L-arabinose for 16 hours. 28°: 0.1 mM IPTG or 0.02% L-arabinose
for 2–3 hours. 37°: 1 mM IPTG or 0.2% L-arabinose for 1 hour. To evaluate expression, 10
μl from each culture-well were added to 200 μl of 20mM Tris-HCl, 150 mM NaCl. 1%SDS,
pH 7.5 in a deep-well block. This block was then sealed with adhesive aluminum tape and
heated to 95° for 10 minutes. Samples were cooled to room temperature before application
onto nitrocellulose membrane using a 96-well vacuum manifold (Biorad). For visualization of
His-tagged protein content, a single step nickel-HRP conjugate was used (His-probe, Pierce).
Membrane associated expression
20ml cultures were grown according to previously identified conditions. Cells were disrupted
by sonication and debris was removed by centrifugation at 10,000xg for 5 minutes. Membranes
were collected by ultra-centrifugation at 150,000xg for 20 minutes. His-tagged protein content
of the membrane fraction was analyzed either by dot-blot or by SDS-PAGE.
For semi-quantitative analysis of His-tagged protein content, micrographs were scanned using
an Alpha Innotech imager. Protein bands (or dots) were quantified using the NIH Image 1.62
software.
Detergent extraction
Detergents were added to a final concentration of 1% to a 1mg/ml membrane protein
suspension. Samples were agitated for 30 minutes at 4°, and insoluble material was removed
by ultra-centrifugation at 100,000xg for 20 minutes. His-tagged protein content of the soluble
fraction was analyzed either by dot-blot or by SDS-PAGE.
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Purifications
1 liter cultures were grown according to previously identified conditions. Cells (typically 3–5
grams per liter of culture) were collected by centrifugation and disrupted using a microfluidizer
processor (Microfluidics, MA, USA) at ~18,000 psi. Prior to disruption, DNAse I (Sigma) was
added at 30 μg/ml to reduce the viscosity of the suspension. Unbroken cells and debris were
removed by centrifugation at 8,000xg for 10 minutes, and membranes were collected by ultra-
centrifugation. The soluble fraction following detergent extraction was directly added to 1.5
ml of Ni-NTA super-flow resin (Qiagen) or 1.5 ml of Talon resin (ClonTech). Following 16
hours of gentle agitation at 4°, the resin was collected by brief centrifugation (2 minutes at
700xg) and moved to disposable 10 ml columns. Contaminants were removed by washing with
20 column volumes of 20mM Tris-HCl pH 8, 500mM NaCl, 5mM β-ME, 20mM imidazole
and detergent at a final concentration of 1–3 X the CMC. Additional washes with 40–100mM
imidazole were used for some proteins, and elution of the His-tagged targets was observed at
100–350mM imidazole (protein specific). Purity of eluted fractions was visualized by
coomassie-blue staining of SDS-PAGE gels.
Gel filtration analysis and stability assays
Purified proteins were concentrated to using a 100KDa concentrator (Amicon-Ultra, Millipore)
and washed once by a ten-fold addition of buffer without imidazole. Protein concentrations
were measured by absorbance at 280 nm or with Bio-rad’s RC DC Protein Assay kit. Typically,
100μl of concentrated protein (10–20 mg/ml) were injected onto a Superdex 200 gel filtration
column (GE Healthcare). Samples were injected either at time of preparation or following 7–
10 days of storage in different conditions, as indicated.
Metal sensitivity assays
Cultures of E. coli W3110 or E. coli GG4839. expressing the indicated proteins were diluted
to optical density (600nm) of 0.05 in 150 μl of Luria Bertani medium supplemented with 0.01%
L-arabinose. Cells were grown in 96-well plates in an automated plate reader (Saffire II, Tecan
Austria) with increasing amounts of ZnCl2 or CdCl2.
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Figure 1.
Expression in whole cell lysates: (A) Growth in an automated plate reader of E. coli BL21
(DE3) Gold expressing 48 different pBAD constructs (left panel) and 48 different pET
constructs (Right panel). Arrows indicate time of induction. (B) Dot blot analysis of whole cell
lysates of 64 pBAD constructs. Wells C6 and C7: ORF Q9HXV0 His-tagged at the N or C-
terminus, respectively. Wells F6 and F7: Cu(1–6)-ZntA His-tagged or Myc-His-tagged,
respectively. (C) Distribution of highly expressing clones according to tag position and vector
type.
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Figure 2.
Membrane-associated expression: (A) Western blot analysis of his-tagged protein expression
in the membrane fraction. 1: C- and N- terminal his tagged versions of ORF O29777. 2: C-
and N- terminal his tagged versions of ORF Q1LKZ4. 3: C-V5-His and C-His tagged versions
of ORF Q9PNE0. 4: C-terminal his and C-terminal Myc-his tagged versions of Cu(6)-ZntA
(B) Distribution of highly expressed membrane-fraction constructs according to tag position
and vector type. (C) Correlation between expression levels observed in whole cells and those
observed in the membrane fraction. Left panel; pBAD constructs, Right panel pET constructs.
In both panels, each point is an individual protein, and the linear fit is depicted as a solid line.
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In the right panel only, the dashed line represents the linear fit when only data up to 8μg protein
per ml of culture is included.
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Figure 3.
Western blot analysis of detergent extraction assays. (A) Membrane vesicles of 11 different
proteins (accession numbers given on top of each panel) were incubated with 1% dodecyl-β-
D-maltoside (DDM). T: total membrane fraction content. S: soluble fraction following
detergent extraction. (B) Soluble fractions following detergent extraction of ORF’s
Q9HXV0, Q1LKZ4, and Q9PNE0 as indicated. 1% of either Fos-choline 14 (Fch), octyl-β-
D-glucopyranoside (OG), dodecyl-β-D-maltoside (DDM), N,N-dimethyldodecylamine-N-
oxide (LDAO) were used.
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Figure 4.
Coomassie-Blue stained SDS gel electrophoresis analysis of protein purification through Ni-
NTA affinity chromatography. Six purifications are shown, with accession numbers indicated
adjacent to each panel. Lanes 1: Total membrane protein, Lanes 2: Soluble fraction following
detergent extraction, Lanes 3: Unbound material. Lanes 4: Wash with 60mM imidazole, Lanes
5: Wash with 100mM imidazole, Lanes 6: Wash with 200mM imidazole, Lanes 7 (were
applicable): Wash with 350mM imidazole.
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Figure 5.
Elution profiles following size exclusion chromatography of different protein preparations,
with accession numbers indicated adjacent to each panel. Profiles shown are at time of
preparation (fresh protein), or following 10-day storage at either 4°, room temperature (RT),
or liquid nitrogen (N2). (B) Elution profile of ORF Q9HUY5 before or after ultracentrifugation.
(C) Elution profiles of ORF Q9HUY5 when either dodecyl-β-D-maltoside (DDM) or octyl-
β-D-glucopyranoside (OG) were used for extraction.
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Figure 6.
Metal-sensitivity growth experiments. E. coli W3110 (Wt strain, insensitive to metals) or E.
coli GG48 (mutant strain, sensitive to Cd+2 and Zn+2) were cultured in the presence of the
indicated metal concentrations. In all panels: Squares: W3110/pBAD N (empty vector), circles
GG48/pBAD N (empty vector), triangles: GG48 cells expressing the N-terminal tagged version
of the indicated protein, crosses: GG48 cells expressing the C-terminal tagged version of the
indicated protein. (A) Ralstonia metallidurans ZntA; (B) Ralstonia metallidurans CadA; (C)
Human-Eschericia coli chimera Cu(6)-ZntA; (D) Eschericia coli ZntA
Lewinson et al. Page 19
J Mol Biol. Author manuscript; available in PMC 2009 January 23.
H
H
M
I Author M
anuscript
H
H
M
I Author M
anuscript
H
H
M
I Author M
anuscript
Figure 7.
Summary of the funnel approach presented in this work, with the number of gene products
remaining at each stage indicated.
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Table 1
List of genes described in this work. Proteins that expressed well in the membrane fraction are denoted with an asterix
preceding the Accession number. Proteins that expressed well and survived to the end of the funnel are preceded with
an additional asterix. Within the Phylum Proteobacteria, E. coli, C. jejuni, H. pylori, R. radiobacter, P. aeruginosa,
R. metallidurans and P. mirabilis are in the γ–, ε–, ε–, α–, γ–, β–, α–, proteobacteria classes, respectively. S.
pneumoniae and L. plantarum belong to the Phylum Firmicutes, while P. furiosus, T. volcanium and A. fulgidus belong
to the Domain Archaea, Phylum Euryarchaeota (reference 44).
Organism Accession number Organism Accession number
Escherichia coli *P37617 Streptococcus pneumoniae P35597
Escherichia coli *NA1 Thermoplasma volcanium Q978Z8
Escherichia coli *P0ABB8 Pseudomonas aeruginosa **Q9HXV0
Escherichia coli *P03960 Pseudomonas aeruginosa Q9HX93
Campylobacter jejuni **Q9PNE0 Pseudomonas aeruginosa *Q9I147
Campylobacter jejuni Q9PND4 Pseudomonas aeruginosa *Q9I3G8
Campylobacter jejuni Q7AR91 Pseudomonas aeruginosa **Q9HUY5
Pyrococcus furiosus Q8TH11 Archaeoglobus fulgidis **O29777
Helicobacter pylori P55989 Archaeoglobus fulgidis **O30085
Helicobacter pylori O26033 Ralstonia metallidurans **Q1LEH0
Helicobacter pylori Q59465 Ralstonia metallidurans *Q1LKZ44
Rhizobium radiobacter *Q8UH42 Ralstonia metallidurans **Q1LKZ45
Rhizobium radiobacter **Q8UG47 Ralstonia metallidurans *Q1LKZ46
Rhizobium radiobacter **Q8UGU8 Ralstonia metallidurans *Q1LAJ7
Rhizobium radiobacter *Q8UF71 Proteus mirabilis *O33448
Streptococcus pneumoniae Q97RR4 Human-E. coli chimera *NA2
Streptococcus pneumoniae Q97NE2 Human-E. coli chimera *NA3
Streptococcus pneumoniae *Q97PQ2 Lactobacillus plantarum Q88VW3
NA: Not applicable.
1,2,3Δ-ZntA, Cu(6)-ZntA, and Cu(1–6)-ZntA, respectively, from 35.
4,5,6
Alternative ORF’s starting at the 1st, 51st, or 103rd amino acid respectively.
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